Skip to main content
. Author manuscript; available in PMC: 2014 Jun 23.
Published in final edited form as: Mult Scler. 2013 Oct 7;20(6):660–668. doi: 10.1177/1352458513506503

Figure 2.

Figure 2

Comparison of MSGB, according to OCB positivity.

(a) Total MSGB boxplots for OCB-negative and OCB-positive MS patients, and controls, in Oslo cohort.

(b) Total MSGB excluding HLA contribution (non-HLA MSGB) boxplots for OCB-negative and OCB-positive MS patients, and controls, in Oslo cohort.

(c) Total MSGB boxplots for OCB-negative and OCB-positive MS patients, and controls, in UCSF cohort.

(d) Total MSGB excluding HLA contribution (non-HLA MSGB) boxplots for OCB-negative and OCB-positive MS patients in the UCSF cohort.

HLA: Human leukocyte antigen; MS: multiple sclerosis; MSGB: MS genetic burden; OCB: oligoclonal band; UCSF: University of CA, San Francisco.